Teyton L, Lotteau V, Boyer B, Charron D J
J Immunol Methods. 1986 May 1;89(1):73-9. doi: 10.1016/0022-1759(86)90033-5.
A quantitative method for the evaluation of human HLA-DR antigen expression has been developed. Cell membrane proteins were solubilized in Nonidet P-40 or deoxycholic acid detergent and diluted in a Triton X-100 containing sample buffer. The samples were subsequently spotted on a nitrocellulose membrane filter and fixed by immersion in isopropyl alcohol-acetic acid solution. The membrane was saturated in a 5% BSA blocking buffer and sequentially incubated with specific monoclonal anti-HLA-DR antibody, and 125I-labelled protein A. Each spot was then assayed for radioactivity in a gamma scintillation counter. Immunoadsorbant purified HLA-DR antigen was used to standardize the method and a reference dosage curve was established with serial dilutions of the purified HLA-DR antigen. The method permitted the detection of HLA-DR antigens with reproducibility in the ng range, in cellular extracts, physiological and pathological fluids, and in fractions eluted from affinity columns.
已开发出一种评估人类HLA - DR抗原表达的定量方法。细胞膜蛋白在去氧胆酸钠或NP - 40去污剂中溶解,并在含Triton X - 100的样品缓冲液中稀释。随后将样品点样于硝酸纤维素膜滤器上,通过浸入异丙醇 - 乙酸溶液进行固定。该膜在5%牛血清白蛋白封闭缓冲液中饱和,依次与特异性单克隆抗HLA - DR抗体和125I标记的蛋白A孵育。然后在γ闪烁计数器中测定每个点的放射性。使用免疫吸附纯化的HLA - DR抗原对该方法进行标准化,并通过纯化的HLA - DR抗原系列稀释建立参考剂量曲线。该方法能够在纳克范围内重现性地检测细胞提取物、生理和病理体液以及从亲和柱洗脱的组分中的HLA - DR抗原。